Next Article in Journal
First Identification of RNA-Binding Proteins That Regulate Alternative Exons in the Dystrophin Gene
Next Article in Special Issue
Clonal Hematopoiesis, Cardiovascular Diseases and Hematopoietic Stem Cells
Previous Article in Journal
NLRP3 as Putative Marker of Ipilimumab-Induced Cardiotoxicity in the Presence of Hyperglycemia in Estrogen-Responsive and Triple-Negative Breast Cancer Cells
Previous Article in Special Issue
Prediction Power on Cardiovascular Disease of Neuroimmune Guidance Cues Expression by Peripheral Blood Monocytes Determined by Machine-Learning Methods
Review

Shear Stress-Induced Activation of von Willebrand Factor and Cardiovascular Pathology

1
National Medical Research Centre of Cardiology of the Ministry of Health of the Russian Federation, 15A, 3-rd Cherepkovskaya Street, 121552 Moscow, Russia
2
State Research Center of the Russian Federation—Institute of Biomedical Problems of Russian Academy of Sciences, 76A, Khoroshevskoye Shosse, 123007 Moscow, Russia
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2020, 21(20), 7804; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21207804
Received: 19 September 2020 / Revised: 19 October 2020 / Accepted: 20 October 2020 / Published: 21 October 2020
The von Willebrand factor (vWF) is a plasma protein that mediates platelet adhesion and leukocyte recruitment to vascular injury sites and carries coagulation factor VIII, a building block of the intrinsic pathway of coagulation. The presence of ultra-large multimers of vWF in the bloodstream is associated with spontaneous thrombosis, whereas its deficiency leads to bleeding. In cardiovascular pathology, the progression of the heart valve disease results in vWF deficiency and cryptogenic gastrointestinal bleeding. The association between higher plasma levels of vWF and thrombotic complications of coronary artery disease was described. Of note, it is not the plasma levels that are crucial for vWF hemostatic activity, but vWF activation, triggered by a rise in shear rates. vWF becomes highly reactive with platelets upon unfolding into a stretched conformation, at shear rates above the critical value (more than 5000 s−1), which might occur at sites of arterial stenosis and injury. The activation of vWF and its counterbalance by ADAMTS-13, the vWF-cleaving protease, might contribute to complications of cardiovascular diseases. In this review, we discuss vWF involvement in complications of cardiovascular diseases and possible diagnostic and treatment approaches. View Full-Text
Keywords: von Willebrand factor; ADAMTS-13; atherosclerosis; atherothrombosis; coronary artery disease; Heyde’s syndrome von Willebrand factor; ADAMTS-13; atherosclerosis; atherothrombosis; coronary artery disease; Heyde’s syndrome
Show Figures

Figure 1

MDPI and ACS Style

Okhota, S.; Melnikov, I.; Avtaeva, Y.; Kozlov, S.; Gabbasov, Z. Shear Stress-Induced Activation of von Willebrand Factor and Cardiovascular Pathology. Int. J. Mol. Sci. 2020, 21, 7804. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21207804

AMA Style

Okhota S, Melnikov I, Avtaeva Y, Kozlov S, Gabbasov Z. Shear Stress-Induced Activation of von Willebrand Factor and Cardiovascular Pathology. International Journal of Molecular Sciences. 2020; 21(20):7804. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21207804

Chicago/Turabian Style

Okhota, Sergey, Ivan Melnikov, Yuliya Avtaeva, Sergey Kozlov, and Zufar Gabbasov. 2020. "Shear Stress-Induced Activation of von Willebrand Factor and Cardiovascular Pathology" International Journal of Molecular Sciences 21, no. 20: 7804. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21207804

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop